Poor pregnancy outcome for women with Type 2 diabetes.

Poor pregnancy outcome for women with Type 2 diabetes.

Detalles Bibliográficos
Autores principales:	Hadden, DR, Cull, C, Croft, D, Holman, R
Formato:	Journal article
Lenguaje:	English
Publicado:	2003

Ejemplares similares

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.
por: Colagiuri, S, et al.
Publicado: (2002)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
por: Cull, C, et al.
Publicado: (2007)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
por: Stratton, I, et al.
Publicado: (2000)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
por: Cull, C, et al.
Publicado: (2004)

Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
por: Cull, C, et al.
Publicado: (2007)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
por: Cull, C, et al.
Publicado: (2001)

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
por: Davis, T, et al.
Publicado: (2001)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
por: Cull, C, et al.
Publicado: (1995)

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
por: Holman, R, et al.
Publicado: (1999)

Glycaemia and vascular effects of type 2 diabetes - Reply
por: Stratton, I, et al.
Publicado: (2001)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
por: Eeley, E, et al.
Publicado: (1996)

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
por: Retnakaran, R, et al.
Publicado: (2006)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
por: Eeley, E, et al.
Publicado: (1996)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
por: Cull, C, et al.
Publicado: (2000)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
por: Wright, A, et al.
Publicado: (1998)

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.
por: Clarke, P, et al.
Publicado: (2006)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
por: Adler, A, et al.
Publicado: (2003)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
por: Turner, R, et al.
Publicado: (1999)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
por: Turner, R, et al.
Publicado: (1998)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
por: Price, H, et al.
Publicado: (2007)

Pregnancy outcomes in women with diabetes mellitus – the impact of diabetes type and treatment
por: Gauri Bapayeva, et al.
Publicado: (2022-02-01)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
por: Wright, A, et al.
Publicado: (2002)

Diabetes in pregnancy: time to focus on women with type 2 diabetes
por: Hirst, JE, et al.
Publicado: (2021)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
por: Wright, A, et al.
Publicado: (2006)

Correspondence on sitagliptin and cardiovascular outcomes in type 2 diabetes
por: Holman, R, et al.
Publicado: (2015)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
por: Cull, C, et al.
Publicado: (1993)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
por: Stratton, I, et al.
Publicado: (2006)

UK prospective diabetes study
por: Turner, R, et al.
Publicado: (1996)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
por: Turner, R, et al.
Publicado: (1999)

Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: Systematic review of observational studies
por: Mires Gary J, et al.
Publicado: (2006-10-01)

Adverse pregnancy outcomes in women with diabetes
por: Negrato Carlos, et al.
Publicado: (2012-09-01)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
por: Cull, C, et al.
Publicado: (1999)

A clinical screening tool identifies autoimmune diabetes in adults: response to Fourlanos et al.
por: Davis, T, et al.
Publicado: (2006)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
por: Levy, J, et al.
Publicado: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
por: Levy, J, et al.
Publicado: (1993)

Sitagliptin and cardiovascular outcomes in type 2 diabetes - author's reply
por: Holman, RR, et al.
Publicado: (2015)

Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))
por: Manley, SE, et al.
Publicado: (2001)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
por: Stettler, C, et al.
Publicado: (2006)

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
por: Turner, R, et al.
Publicado: (1996)

United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
por: Turner, R, et al.
Publicado: (1996)